Vanderbilt study suggests way to prevent rare lung disease


Research by Vanderbilt scientists suggests that it may be possible to prevent or even reverse pulmonary arterial hypertension (PAH), a rare, progressive disease characterized by narrowing of and high blood pressure in the small arteries of the lungs.


A key player in PAH is the proangiogenic cell (PAC), a cell produced by the bone marrow that normally promotes the growth of new blood vessels.